Ibuprofen removal through photocatalytic filtration using antifouling PVDF- ZnO/Ag2CO3/Ag2O nanocomposite membrane

The in-situ phase transformation of Ag2CO3/Ag2O heterojunction over ZnO was synthesized via a facile two-step synthesis method and immobilized in poly (vinylidene fluoride) (PVDF) membrane via a phase inversion process to obtain a novel photocatalytic membrane (PM) for ibuprofen (IBU) removal. The...

Full description

Bibliographic Details
Main Authors: Rosman, Nurafiqah, Wan Salleh, Wan Norharyati, Mohd Razali, Nur Aqilah, Ahmad, Siti Zu Nurain, Ismail, Nor Hafiza, Aziz, Farhana, Harun, Zawati, Ismail, Ahmad Fauzi, Yusof, Norhaniza
Format: Other
Language:English
Published: Elsevier 2021
Subjects:
Online Access:http://eprints.uthm.edu.my/6655/1/P13069_a2540f59d49a47bfe6a07975c056b1a0.pdf
Description
Summary:The in-situ phase transformation of Ag2CO3/Ag2O heterojunction over ZnO was synthesized via a facile two-step synthesis method and immobilized in poly (vinylidene fluoride) (PVDF) membrane via a phase inversion process to obtain a novel photocatalytic membrane (PM) for ibuprofen (IBU) removal. The visible-light-driven PVDF ZnO/Ag2CO3/Ag2O membrane possessed a great extent altering its morpholog�ical and wettability properties. The structural characteristics and antifouling property of PMs with the presence of ZnO/Ag2CO3/Ag2O were systematically investigated. The performance analysis indicated that PVDF–ZnO/Ag2CO3/Ag2O showed a higher IBU percentage removal of 27.37% in dark condition. However, as the PVDF–ZnO/Ag2CO3/Ag2O membrane irradiated with visible light, the synergistic effects accom�plished by both, membrane filtration and photocatalysis have significantly enhanced the IBU removal efficacy compared with that via filtration alone, exhibited 35.27% of IBU removal. The photocatalytic activity has remarkably reduced the fouling susceptibility of PVDF–ZnO/Ag2CO3/Ag2O membranes, where the relative flux had reached a relative stable plateau under visible light irradiation after the collection of 150 mL of permeate with 46.85% of flux loss. With its promising performance in terms of IBU removal, flux and low membrane fouling susceptibility, this PM holds great potential for its application in pharma�ceutical wastewater treatment.